ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

Three Scientists Win Albert Lasker Medial Research Awards

September 30, 1994

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

December 28, 2001

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

Funding Mechanisms: How They Are Used

August 12, 1983